We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Rayto Life and Analytical Sciences Co.,Ltd.

Rayto is a manufacturer of IVD devices and related software, including chemistry analyzers, ELISA readers and washers... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Urinary Heat Shock Protein 70 Evaluated in Chronic Prostatitis

By LabMedica International staff writers
Posted on 21 Apr 2021
Print article
Image: The Rayto RT‐6500 microplate reader (Photo courtesy of Rayto Life and Analytical Sciences)
Image: The Rayto RT‐6500 microplate reader (Photo courtesy of Rayto Life and Analytical Sciences)
Chronic prostatitis (CP) is a common, but a confusing urological disease that seriously affects men's lives and health and cannot be ignored. The incidence rate is increasing, and the disease is affecting younger men and long‐term prostatitis affects male sexual function.

The etiology and pathogenesis of CP are very complicated. Studies have shown that the detection of heat shock protein 70 (HSP70) levels in the expressed prostatic secretions (EPS) of CP patients suggests that it is involved in the process of inflammation. However, EPS can be obtained by anal prostate massage, which is noticeably painful, invasive, and intolerable for some patients.

Clinical Laboratory Scientists at the Guangxi Medical University (Nanning, China) explored the diagnostic value of the levels of prostatic exosomal protein (PSEP) and heat shock protein 70 (HSP70) in the urine of patients with chronic prostatitis (CP). Urine samples from 210 CP patients (70 cases of the USA National Institutes of Health Category II [NIH‐II], 70 NIH‐IIIa, and 70 NIH‐IIIb patients) and 70 control subjects were collected between May 2018 and February 2020.

The team used enzyme‐linked immunosorbent assay (ELISA) to detect PSEP and HSP70 in the urine samples. The PSEP kit was provided by Angke Biotechnology Co., Ltd., (Taicang, China) and the HSP70 kit was provided by Shanghai Enzyme Link Biotechnology Co., Ltd (Shanghai City; China). The investigators read and recorded the absorbance value of the Rayto RT‐6500 microplate reader (Rayto Life and Analytical Sciences Co., Shenzhen, China), in dual‐wavelength mode (450 nm is the test wavelength; 630 nm is the reference wavelength). The differences in urine PSEP and HSP70 levels between the groups were analyzed, and receiver operating characteristic (ROC) curves were used to analyze the clinical value of PSEP and HSP70 in the diagnosis of CP.

The investigators reported that the PSEP levels of CP patients were significantly higher than those of the control group, but there was no difference in PSEP levels among CP subgroups. The level of HSP70 in the urine of the NIH‐II patients was significantly lower than the levels in the NIH‐IIIa and NIH‐IIIb subgroups and the control group, but there was no difference in HSP70 levels between the NIH‐IIIa and NIH‐IIIb subgroups and the control group. ROC curve analysis results showed that the area under the curve (AUC) of PSEP for the NIH‐II, NIH‐IIIa, and NIH‐IIIb patients was 0.751, 0.776, and 0.731, respectively. The AUC of HSP70 in NIH‐II patients was 0.784, and the AUC of combined detection of PSEP and HSP70 in NIH‐II patients was 0.858.

The authors concluded that urinary PSEP can be used as a marker for the diagnosis of CP, but it cannot distinguish the CP subtypes, and HSP70 can be used as a diagnostic index for NIH‐II classification. Both provide a novel, simple, non‐invasive, and painless molecular detection method for CP diagnosis. The study was published on April 6, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
Guangxi Medical University
Angke Biotechnology Co., Ltd
Shanghai Enzyme Link Biotechnology
Rayto Life and Analytical Sciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.